{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:45Z","timestamp":1707524265680},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,2]]},"DOI":"10.7759\/cureus.17659","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T13:58:34Z","timestamp":1630591114000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Burkitt\u2019s Lymphoma Presenting With Features Mimicking Vogt-Koyanagi-Harada Disease"],"prefix":"10.7759","author":[{"given":"Ramya","family":"Tadipatri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraj","family":"Muley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekokobe","family":"Fonkem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Azadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0412-4","article-title":"Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes","volume":"11","author":"Lavezzo MM","year":"2016","unstructured":"Lavezzo MM, Sakata VM, Morita C, et al.. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016, 11:29. 10.1186\/s13023-016-0412-4","journal-title":"Orphanet J Rare Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_544_16","article-title":"Management of a rare presentation of Vogt-Koyanagi-Harada disease in human immunodeficiency virus\/acquired immunodeficiency disease syndrome patient","volume":"65","author":"Priya D","year":"2017","unstructured":"Priya D, Sudharshan S, Biswas J. Management of a rare presentation of Vogt-Koyanagi-Harada disease in human immunodeficiency virus\/acquired immunodeficiency disease syndrome patient. Indian J Ophthalmol. 2017, 65:413-6. 10.4103\/ijo.IJO_544_16","journal-title":"Indian J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.051953","article-title":"HIV infection and lymphoma","volume":"60","author":"Grogg KL","year":"2007","unstructured":"Grogg KL, Miller RF, Dogan A. HIV infection and lymphoma. J Clin Pathol. 2007, 60:1365-72. 10.1136\/jcp.2007.051953","journal-title":"J Clin Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-538504","article-title":"How I treat Burkitt lymphoma in adults","volume":"124","author":"Jacobson C","year":"2014","unstructured":"Jacobson C, LaCasce A. How I treat Burkitt lymphoma in adults. Blood. 2014, 124:2913-20. 10.1182\/blood-2014-06-538504","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1308392","article-title":"Low-intensity therapy in adults with Burkitt's lymphoma","volume":"369","author":"Dunleavy K","year":"2013","unstructured":"Dunleavy K, Pittaluga S, Shovlin M, et al.. Low-intensity therapy in adults with Burkitt's lymphoma. N Engl J Med. 2013, 369:1915-25. 10.1056\/NEJMoa1308392","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study","volume":"13","author":"Mead GM","year":"2002","unstructured":"Mead GM, Sydes MR, Walewski J, et al.. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol. 2002, 13:1264-74. 10.1093\/annonc\/mdf253","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-004-0177-5","article-title":"A case of Vogt-Koyanagi-Harada disease associated with malignant lymphoma","volume":"49","author":"Hashida N","year":"2005","unstructured":"Hashida N, Kanayama S, Kawasaki A, Ogawa K. A case of Vogt-Koyanagi-Harada disease associated with malignant lymphoma. Jpn J Ophthalmol. 2005, 49:253-6. 10.1007\/s10384-004-0177-5","journal-title":"Jpn J Ophthalmol"},{"key":"ref8","article-title":"Characterization of T-cell subsets, soluble interleukin-2 receptors and interleukin-6 in Vogt-Koyanagi-Harada disease","volume":"36","author":"Kogiso M","year":"1992","unstructured":"Kogiso M, Tanouchi Y, Miki S, Mimura Y. Characterization of T-cell subsets, soluble interleukin-2 receptors and interleukin-6 in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1992, 36:37-43.","journal-title":"Jpn J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/09273940802023810","article-title":"Intravascular lymphoma masquerading as Vogt-Koyanagi-Harada syndrome","volume":"16","author":"Pahk PJ","year":"2008","unstructured":"Pahk PJ, Todd DJ, Blaha GR, et al.. Intravascular lymphoma masquerading as Vogt-Koyanagi-Harada syndrome. Ocul Immunol Inflamm. 2008, 16:123-6. 10.1080\/09273940802023810","journal-title":"Ocul Immunol Inflamm"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3343\/kjlm.2010.30.6.600","article-title":"Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2R\u03b1) in patients with non-Hodgkin's lymphoma","volume":"30","author":"Jo SA","year":"2010","unstructured":"Jo SA, Hwang SH, Chang CL, et al.. Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2R\u03b1) in patients with non-Hodgkin's lymphoma. Korean J Lab Med. 2010, 30:600-5. 10.3343\/kjlm.2010.30.6.600","journal-title":"Korean J Lab Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-1229(05)80025-x","article-title":"Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change","volume":"61","author":"Hofmann B","year":"1991","unstructured":"Hofmann B, Nishanian P, Fahey JL, Esmail I, Jackson AL, Detels R, Cumberland W. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change. Clin Immunol Immunopathol. 1991, 61:212-224. 10.1016\/s0090-1229(05)80025-x","journal-title":"Clin Immunol Immunopathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14288","article-title":"Age-related heterogeneity of Burkitt lymphoma","volume":"180","author":"Mbulaiteye SM","year":"2018","unstructured":"Mbulaiteye SM, Anderson WF. Age-related heterogeneity of Burkitt lymphoma. Br J Haematol. 2018, 180:153-5. 10.1111\/bjh.14288","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65325-a-rare-case-of-burkitts-lymphoma-presenting-with-features-mimicking-vogt-koyanagi-harada-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:25:02Z","timestamp":1707506702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65325-a-rare-case-of-burkitts-lymphoma-presenting-with-features-mimicking-vogt-koyanagi-harada-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.17659","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,2]]}}}